Skip to content

Global Physician Dispensed Cosmeceuticals Market to Reach $24.9 Billion by 2026

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies – Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to our digital archives and MarketGlass Research Platform
  • Complimentary updates for one year

Edition: 17; released: March 2022
Executive Pool: 761
Companies: 91 – Players covered include Allergan Plc; Athena Cosmetics, Inc.; Biopelle, Inc.; Clinique Laboratories, LLC; Emerson Ecologics, LLC; IS CLINICAL; Jan Marini Skin Research, Inc.; La Roche-Posay Laboratoire Pharmaceutique; Neutrogena Corp.; Obagi Medical Products, Inc.; SkinCeuticals; SkinMedica, Inc.; Solta Medical, Inc.; Stiefel Laboratories, Inc.; ZO® Skin Health, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Product Type (Skin Care, Hair Care, Eye Care, Injectable Botox, Other Product Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels)
Geographies: World; USES; Canada; Japanese; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazilian; Mexico; Rest of Latin America; Middle East; Iran; Israel; saudi arabia; UAE; Rest of Middle East; Africa.

Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Physician Dispensed Cosmeceuticals Market to Reach $24.9 Billion by 2026
The term ‘physician-dispensed cosmeceuticals’ refers to cosmeceutical products that are sold through physician clinics or offices. Physician dispensed cosmeceuticals can be used on their own or in combination with other aesthetic procedures or treatments. Physician dispensed cosmeceuticals market globally is witnessing a steady growth, driven primarily by the rising demand from patients with high aesthetic consciousness. Despite the easy and increasing availability of professional skin care products, customers are demonstrating preference for cosmeceuticals sold by the physician’s office, as they are thought to offer better results. Patients are also expressing higher confidence in using products prescribed by their physicians, especially given the explosion in options available in the mass marketplace which are difficult to compare or differentiate. The market is also sensitive to economic environment, with financial downturns having an adverse impact on the market for physician dispensed cosmeceuticals market.

Amid the COVID-19 crisis, the global market for Physician Dispensed Cosmeceuticals estimated at US$17.3 Billion in the year 2022, it is projected to reach a revised size of US$24.9 Billion by 2026, growing at a CAGR of 8.5% over the analysis period. Skin Care, one of the segments analyzed in the report, is projected to grow at a 9.5% CAGR to reach US$12 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hair Care segment is readjusted to a revised 8.2% CAGR for the next 7-year period. This segment currently accounts for a 23.3% share of the global Physician Dispensed Cosmeceuticals market. Skincare products account for a major share of the global physician dispensed cosmeceuticals market. Physician-dispensed skin care products are designed to target the root cause of various skin problems, thus ensuring comprehensive and long-term benefits. Such products typically include high-concentrations of active ingredients, when compared to over-the-counter products or mass products, thus playing a vital role in enhancing their overall effectiveness. Demand for physician branded skincare products in aesthetic medical practices is experiencing strong growth, led by the rising interest in specialty products that meet specific needs of customers opting for cosmetic procedures.

The US Market is Estimated at $6.5 Billion in 2022, While China is Forecast to Reach $1.9 Billion by 2026
The Physician Dispensed Cosmeceuticals market in the US is estimated at US$6.5 Billion in the year 2022. The country currently accounts for a 37.66% share in the global market. Chinathe world’s second largest economy, is forecast to reach an estimated market size of US$1.9 Billion in the year 2026 trailing a CAGR of 10.7% through the analysis period. Among the other noteworthy geographic markets are Japanese and Canada, each forecast to grow at 7.2% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR while Rest of European market (as defined in the study) will reach US$2.1 Billion by the close of the analysis period.

The market is being fueled by the ineffectiveness of non-prescription cosmetics in meeting the consumer needs and the promise of enhanced results offered by prescription products. Patients are showing greater confidence in products recommended by physicians owing to their ability to improve appearance of the skin. Driven by the growing level of consumer confidence in physician-prescribed products, the market for physician-dispensed cosmeceutical products is expected to post steady growth in the coming years. Rising consumer demand for effective and high-quality products for promoting both health and beauty is driving physicians to prescribe cosmeceutical products for offering support to overall skin health and prevent signs of aging. Changing consumer preferences, the highly stressful lives of consumers, increasing pollution levels and the subsequent damage caused to skin, hair and eyes of people is driving growth in the global market for physician dispensed cosmeceuticals. The growing awareness about maintaining physical appearance among the world’s expanding elderly population and changing attitudes of the geriatric and middle aged population in developing economies present significant opportunities for the physician dispensed cosmeceuticals market. Rising awareness about new skin conditions attributed to pollution and climate change and the growing demand for branded cosmeceuticals due to their improved efficacy and safety levels are expected to foster growth in the global physician dispensed cosmeceuticals market. Companies are increasingly investing in research and development initiatives to create new products and to stay competitive. Going forwards, product premiumization is set to fuel overall sales. Another factor expected to bring significant sales improvement is the continuous increase in the number of dispensing physicians every year. Besides, deepening Internet penetration and increasing usage of Internet and e-Commerce as a marketing channel is expected to drive future sales.

Eye Care Segment to Reach $4.3 Billion by 2026
This segment includes prescription drops, artificial tears, and other eye care products. The segment covers eye care products aimed at strengthening and stimulating the re-growth of eyelashes. In the global Eye Care segment, USES, Canada, Japanese, China and Europe will drive the 7.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.1 Billion will reach a projected size of US$3.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, Indiaand South Koreathe market in Asia-Pacific is forecast to reach US$434.5 million by the year 2026, while Latin America will expand at an 8.7% CAGR through the analysis period. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include – enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
E-mail: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

SOURCE Global Industry Analysts, Inc.

.